VivoSeq
Other

Gut Microbiome

1

Pipeline Programs↗

7

Active Trials↗

1

Companies Involved↗

Gut Microbiome is an early-stage landscape with 1 program across 1 company. The most active players are Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved1

L-Phenylalanine Veg

Weill Medical College of Cornell University

Analysis

Trial Status

27

clinical trials

Completed9 · 33%
Unknown status8 · 30%
Recruiting3 · 11%
Terminated2 · 7%
Active, not recruiting2 · 7%
Withdrawn1 · 4%
Other2 · 7%

Clinical Trials

Trial Activity

27 trials

Effect of Gut Microbiome Intervention on Aging Via Oral FMT
Recruiting·—·Phase 1·NCT05598112·210 enrolled
Oral Aromatase Inhibitors Modify the Gut Microbiome
Recruiting·WWake Forest University Health Sciences·N/A·NCT05030038·25 enrolled
Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study
Recruiting·WWeill Medical College of Cornell University·Approved·NCT06433310·20 enrolled
Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome
Active, not recruiting·MMedical University of Graz·Phase 4·NCT05737030·55 enrolled
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
Active, not recruiting·OOslo University Hospital·Phase 4·NCT04207177·100 enrolled
Autoflor -Lyophilized Capsulated Autological FMT to Restore Gut Microbiome After Treatment With Antibiotics
Not yet recruiting·—·N/A·NCT06250413·40 enrolled
Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study
Enrolling by invitation·PPauls Stradins Clinical University Hospital·N/A·NCT06846138·66 enrolled
Effect of Metformin and Probiotics on Gut Microbiome in Healthy Subjects
Completed·TThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School·N/A·NCT03756623·90 enrolled
Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT05930197·34 enrolled
Effect of Prebiotics on the Gut Microbiome Profile and Beta Cell Function
Completed·IIndiana University·Phase 1·NCT04114357·12 enrolled
Effect of Aspirin on Gut Microbiome
Completed·UUniversity of Minnesota·Phase 1·NCT02761486·50 enrolled
Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers
Completed·AAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections·Phase 2·NCT02706717·93 enrolled
Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES)
Completed·—·N/A·NCT02893709·36 enrolled
Effect of Antibiotics on Gut Microbiome and Plasma Metabolome
Completed·FFinnish Institute for Health and Welfare·Phase 4·NCT03273296·39 enrolled
The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome
Completed·NNYU Langone Health·Phase 2·NCT03452189·15 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)